A significant benefit was observed with Tysabri over Rebif in delaying SPMS disability progression when therapeutic lag was accounted for.

Tysabri is another DMT considered highly effective. Platform therapies are those that are less effective but were used as first-line treatment before more effective therapies were approved ...